Centre de Regulacio Genomica:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Centre de Regulacio Genomica - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9426
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centre de Regulacio Genomica (CRG) is a biomedical institute that offers healthcare research services. The institute offers research programs such as bioinformatics and genomics, cell and developmental biology, gene regulation, stem cells and cancer and systems biology, among others. It offers light microscopy unit, bioinformatics unit, biomolecular screening, protein technologies unit, and other facilities. CRG operates units for genomics, histology and scientific information technologies. The institute offers courses for undergraduates, PhD students, postdoctoral, researchers and scientists. It also provides technology transfer services. CRG is headquartered in Barcelona, Spain.

Centre de Regulacio Genomica – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Centre de Regulacio Genomica Enters into Agreement with EUGIN Clinic 10
Centre for Genomic Regulation Enters Into Co-Development Agreement With Illumina 11
Centre For Genomic Regulation Enters Into Research Agreement With Sanofi 12
Centre de Regulacio Genomica Enters Into Research Agreement With Sanofi 13
Centre de Regulacio Genomica – Key Competitors 14
Centre de Regulacio Genomica – Key Employees 15
Centre de Regulacio Genomica – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Jan 02, 2018: New approaches in genomic medicine: A step forward in Parkinson’s disease 17
Dec 19, 2017: New approaches in medical genomics: A step forward in Parkinson’s disease 18
Product News 19
Jul 10, 2018: Big Data analysis identifies new cancer risk genes 19
Jun 05, 2018: New tool enables big-scale analysis of single cells 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Key Facts 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre de Regulacio Genomica, Deals By Therapy Area, 2012 to YTD 2018 8
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centre de Regulacio Genomica Enters into Agreement with EUGIN Clinic 10
Centre for Genomic Regulation Enters Into Co-Development Agreement With Illumina 11
Centre For Genomic Regulation Enters Into Research Agreement With Sanofi 12
Centre de Regulacio Genomica Enters Into Research Agreement With Sanofi 13
Centre de Regulacio Genomica, Key Competitors 14
Centre de Regulacio Genomica, Key Employees 15

List of Figures
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Centre de Regulacio Genomica:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • University of Leeds:医療機器:M&Aディール及び事業提携情報
    Summary University of Leeds (University of Leeds) is an educational university that offers academic programs. The university offers undergraduate, post graduate, research degrees, online and distance learning educational programs. It offers education programs in the areas of arts, biological science …
  • NTT DATA Corporation (9613):企業の財務・戦略的SWOT分析
    NTT DATA Corporation (9613) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Darden Restaurants, Inc.:戦略・SWOT・企業財務分析
    Darden Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report Summary Darden Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • National Cancer Centre Singapore-製薬・医療分野:企業M&A・提携分析
    Summary National Cancer Centre Singapore (NCCS) is a healthcare service provider that offers research and cancer treatment services. The center offers research for cancers such as breast, gynaecology, haematology, head and neck, neuro oncology, naso pharynx cancer, paediatrics, reconstructive, hepat …
  • Novacyt SA (ALNOV):医療機器:M&Aディール及び事業提携情報
    Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt deve …
  • Great Portland Estates Plc (GPOR):企業の財務・戦略的SWOT分析
    Great Portland Estates Plc (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Fujirebio Europe NV:企業の戦略的SWOT分析
    Fujirebio Europe NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Interface Biologics Inc:製品パイプライン分析
    Summary Interface Biologics Inc (IBI) is a developer transformative biomedical polymer technology. The company offers anti-thrombogenic and combination drug delivery devices. Its blood contacting medical devices uses Endexo technology address problems related to thrombosis. IBI’s technologies includ …
  • GS Engineering & Construction Corp (006360):企業の財務・戦略的SWOT分析
    GS Engineering & Construction Corp (006360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • General Motors Co (GM):企業の財務・戦略的SWOT分析
    General Motors Co (GM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Shionogi & Co Ltd (4507):企業の財務・戦略的SWOT分析
    Shionogi & Co Ltd (4507) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Timberland LLC:戦略・SWOT・企業財務分析
    Timberland LLC - Strategy, SWOT and Corporate Finance Report Summary Timberland LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Suncor Energy Inc.:企業の戦略・SWOT・財務分析
    Suncor Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary Suncor Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析
    R1 RCM Inc (RCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • University of Texas Health Science Center at San Antonio-製薬・医療分野:企業M&A・提携分析
    Summary University of Texas Health Science Center at San Antonio (UTHSCSA), a subsidiary of University of Texas System is an educational university that offers undergraduate, graduate, and research programs to physicians, biomedical scientists, aging and longevity, cancer, cardiovascular, diabetes, …
  • Ansaldo STS SpA:企業の戦略・SWOT・財務情報
    Ansaldo STS SpA - Strategy, SWOT and Corporate Finance Report Summary Ansaldo STS SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Marksmen Energy Inc (MAH):企業の財務・戦略的SWOT分析
    Summary Marksmen Energy Inc (Marksmen Energy), formerly Marksmen Resources Ltd, is an oil and gas exploration and development company that explores and develops light oil assets in Ohio. The company acquires, explores, operates, manages, produces and develops oil and gas properties in Western Canada …
  • Movenpick Schweiz AG:企業の戦略・SWOT・財務情報
    Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report Summary Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Microsoft Corp (MSFT):医療機器:M&Aディール及び事業提携情報
    Summary Microsoft Corporation (Microsoft) is a technology-based company that develops, licenses, and supports software products, services, and devices. The company offers a comprehensive range of operating systems, cross-device productivity applications, server applications, business solution applic …
  • JXTG Holdings Inc (5020):企業の財務・戦略的SWOT分析
    JXTG Holdings Inc (5020) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆